Upload Avatar (500 x 500)
Zhenming Liu
zmliu@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Pharmaceutical Sciences
  • 1996-2000 Bachelor of Science: Beijing Medical University, School of Pharmaceutical Sciences, Major in Medicinal Chemistry
  • 2000-2005 Doctor of Science: Peking University, College of Chemistry and Molecular Engineering, Major in Physical Chemistry (Doctoral Supervisor: Luhua Lai)
  • 2011-present Researcher, Associate Researcher, Peking University School of Pharmaceutical Sciences
  • 2005-2011 Lecturer, Peking University School of Pharmaceutical Sciences
  • 2007-2009 Office of Major New Drug Creation Science and Technology Major Project Implementation Management
Medicinal Chemistry and Drug Design
  • CMNPD: a comprehensive marine natural products database towards facilitating drug discovery from the ocean, Chuanyu Lyu, Tong Chen, Bo Qiang, Ningfeng Liu, Heyu Wang, Liangren Zhang, Zhenming Liu, 2020
  • Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists, Zhang H, He X, Wang X, Yu B, Zhao S, Jiao P, Jin H, Liu Z, Wang K, Zhang L, Zhang L, 2020
  • Discovery of 2-(2-aminobenzo[d]thiazol-6-yl) benzo[d]oxazol-5-amine derivatives that regulated HPV relevant cellular pathway and prevented cervical cancer from abnormal proliferation, Jiao P, Wang Y, Mao B, Wang B, Zhong Y, Jin H, Zhang L, Zhang L, Liu Z, 2020
  • Privileged Scaffold Analysis of Natural Products with Deep Learning-based Indication Prediction Model, Lai J, Hu J, Wang Y, Zhou X, Li Y, Zhang L, Liu Z, 2020
  • TF3P: Three-Dimensional Force Fields Fingerprint Learned by Deep Capsular Network, Wang Y, Hu J, Lai J, Li Y, Jin H, Zhang L, Zhang LR, Liu ZM, 2020
  • Comprehensive analysis of human IgG Fc N-glycopeptides and construction of a screening model for colorectal cancer, Zou Y, Hu J, Jie J, Lai J, Li M, Liu Z, Zou X, 2020
  • DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning, Li Y, Hu J, Wang Y, Zhou J, Zhang L, Liu Z, 2020
  • ETCM: an encyclopaedia of traditional Chinese medicine, Xu HY, Zhang YQ, Liu ZM, Chen T, Lv CY, Tang SH, Zhang XB, Zhang W, Li ZY, Zhou RR, Yang HJ, Wang XJ, Huang LQ, 2019
  • Direct Gating of the TRPM2 Channel by cADPR via Specific Interactions with the ADPR Binding Pocket, Yu P, Liu Z, Yu X, Ye P, Liu H, Xue X, Yang L, Li Z, Wu Y, Fang C, Zhao YJ, Yang F, Luo JH, Jiang LH, Zhang L, Zhang L, Yang W, 2019
  • Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL, Yang L, Liu Y, Fan M, Zhu G, Jin H, Liang J, Liu Z, Huang Z, Zhang L, 2019
  • Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation, Xue Y, He X, Yang T, Wang Y, Liu Z, Zhang G, Wang Y, Wang K, Zhang L, Zhang L, 2019
  • Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases, Dou X, Huang H, Li Y, Jiang L, Wang Y, Jin H, Jiao N, Zhang L, Zhang L, Liu Z, 2019
  • Rational Design and Identification of Small-Molecule Allosteric Inhibitors of CD38, Yang L, Li T, Li S, Wu Y, Shi X, Jin H, Liu Z, Zhao Y, Zhang L, Lee HC, Zhang L, 2019
  • Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia, Wang Y, Dou X, Jiang L, Jin H, Zhang L, Zhang L, Liu Z, 2019
  • Multi-objective de novo drug design with conditional graph generative model, Li Y, Zhang L, Liu Z, 2018
  • Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors, Zhang H, Liu H, Luo X, Wang Y, Liu Y, Jin H, Liu Z, Yang W, Yu P, Zhang L, Zhang L, 2018
  • Discovery of N-(Naphtho[1,2-b]Furan-5-Yl) Benzenesulfonamides as Novel Selective Inhibitors of Triple-Negative Breast Cancer (TNBC), Chen Y, Tang Y, Mao B, Li W, Jin H, Zhang L, Liu Z, 2018
  • Discovery of new GSK-3β inhibitors through structure-based virtual screening, Dou X, Jiang L, Wang Y, Jin H, Liu Z, Zhang L, 2018
  • Calcium-Mobilizing Behaviors of Neutral Cyclic ADP-Ribose Mimics that Integrate Modifications to the Nucleobase, Northern Ribose and Pyrophosphate, Wang X, Zhang X, Zhang K, Hu J, Liu Z, Jin H, Zhang L, Zhang L, 2018
  • Docking Field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptase, Fan N, Zhang S, Sheng T, Zhao L, Liu Z, Liu J, Wang X, 2017
  • The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing, Luo Q, Zhao L, Hu J, Jin H, Liu Z, Zhang L, 2017
  • Miconazole protects blood vessels from MMP9-dependent rupture and hemorrhage, Yang R, Zhang Y, Huang D, Luo X, Zhang L, Zhu X, Zhang X, Liu Z, Han JY, Xiong JW, 2017
  • Identification of the ADPR binding pocket in the NUDT9 homology domain of TRPM2, Yu P, Xue X, Zhang J, Hu X, Wu Y, Jiang LH, Jin H, Luo J, Zhang L, Liu Z, Yang W, 2017
  • Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors, Wang Z, Niimi M, Ding Q, Liu Z, Wang L, Zhang J, Xu J, Fan J, 2017
  • Eg5 inhibitor YL001 induces mitotic arrest and inhibits tumor proliferation, Wang Y, Wu X, Du M, Chen X, Ning X, Chen H, Wang S, Liu J, Liu Z, Li R, Fu G, Wang C, McNutt MA, Zhou D, Yin Y, 2017
  • Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors, Han X, Zhong Y, Zhou G, Qi H, Li S, Ding Q, Liu Z, Song Y, Qiao X, 2017
  • Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors, Li Y, Kong Y, Zhang M, Yan A, Liu Z, 2016
  • Cytochrome P450 promiscuity leads to a bifurcating biosynthetic pathway for tanshinones, Guo J, Ma X, Cai Y, Ma Y, Zhan Z, Zhou YJ, Liu W, Guan M, Yang J, Cui G, Kang L, Yang L, Shen Y, Tang J, Lin H, Ma X, Jin B, Liu Z, Peters RJ, Zhao ZK, Huang L, 2016
  • A stereo configuration-activity study of 3-iodo-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(2H)-ones as potency inhibitors of HIV-1 variants, Wu S, Yin Q, Zhao L, Fan N, Tang X, Zhao J, Sheng T, Guo Y, Tian C, Zhang Z, Xu W, Liu Z, Jiang S, Ma L, Liu J, Wang X, 2016
  • New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds, Zhang Y, Liu B, Wu X, Li R, Ning X, Liu Y, Liu Z, Ge Z, Li R, Yin Y, 2015
  • Comparative Analysis of Pharmacophore Features and Quantitative Structure–Activity Relationships for CD38 Covalent and Non-covalent Inhibitors, Zhang S, Xue X, Zhang L, Zhang L, Liu Z, 2015
  • Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example, Zeng L, Guan M, Jin H, Liu Z, Zhang L, 2015
  • Enrichment Assessment of Multiple Virtual Screening Strategies for Toll-Like Receptor 8 Agonists Based on a Maximal Unbiased Benchmarking Data Set, Pei F, Jin H, Zhou X, Xia J, Sun L, Liu Z, Zhang L, 2015
  • Antimalarial drug artemisinin depletes erythrocytes by activating apoptotic pathways in zebrafish, Yang R, Yan S, Zhu X, Li CY, Liu Z, Xiong JW, 2015
  • An Unbiased Method To Build Benchmarking Sets for Ligand-Based Virtual Screening and its Application To GPCRs, Xia J, Jin H, Liu Z, Zhang L, Wang XS, 2014
  • Unfolding and Conformational Variations of ThrombinBinding DNA Aptamers: Synthesis, Circular Dichroism and Molecular Dynamics Simulations, Sun L, Jin H, Zhao X, Liu Z, Guan Y, Yang Z, Zhang L, Zhang L, 2014
  • Comparative Analyses
Drug Design Medicinal Chemistry Bioactive Molecules Drug Targets Lead Compounds Structure Modification Drug Discovery Pharmaceutical Sciences Chemical Engineering Biological Activities

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.